These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 17995495

  • 1. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS, Tam WH, Yeo W, Yu MM, Ng DP, Wong AW, Kwan WH, Yuen PM.
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [Abstract] [Full Text] [Related]

  • 2. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J, Konje JC, Hickey M.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400
    [Abstract] [Full Text] [Related]

  • 3. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S, Hickey M, Chin J, Su HI.
    Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916
    [Abstract] [Full Text] [Related]

  • 4. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA, Young K, Hickey M, Su HI.
    Cochrane Database Syst Rev; 2020 Dec 21; 12(12):CD007245. PubMed ID: 33348436
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD, Aydin Y, Atis A, Mandiraci G.
    Climacteric; 2008 Jun 21; 11(3):252-7. PubMed ID: 18568790
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Cuzick J, Coibion M, Bianco AR.
    BJOG; 2003 Dec 21; 110(12):1099-106. PubMed ID: 14664881
    [Abstract] [Full Text] [Related]

  • 8. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial.
    Gardner FJ, Konje JC, Bell SC, Abrams KR, Brown LJ, Taylor DJ, Habiba M.
    Gynecol Oncol; 2009 Sep 21; 114(3):452-6. PubMed ID: 19576623
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis.
    Fu Y, Zhuang Z.
    Int J Clin Exp Pathol; 2014 Sep 21; 7(10):6419-29. PubMed ID: 25400720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I, Bernheim J, Azaria R, Tepper R, Sharony R, Beyth Y.
    Gynecol Oncol; 1999 Oct 21; 75(1):136-41. PubMed ID: 10502440
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P, Johnson N.
    BJOG; 2006 Mar 21; 113(3):257-63. PubMed ID: 16487195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of levonorgestrel-releasing intrauterine system for endometrial protection in women with breast cancer taking tamoxifen.
    Shi Q, Li J, Li M, Wu J, Yao Q, Xing A.
    Eur J Gynaecol Oncol; 2014 Mar 21; 35(5):492-8. PubMed ID: 25423691
    [Abstract] [Full Text] [Related]

  • 16. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial.
    Heliövaara-Peippo S, Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Tomas E, Tuppurainen M, Paavonen J.
    BJOG; 2010 Apr 21; 117(5):602-9. PubMed ID: 20156209
    [Abstract] [Full Text] [Related]

  • 17. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
    Heliövaara-Peippo S, Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Kujansuu E, Tuppurainen M, Vuorma S, Yliskoski M, Paavonen J.
    Acta Obstet Gynecol Scand; 2009 Apr 21; 88(12):1389-96. PubMed ID: 19878089
    [Abstract] [Full Text] [Related]

  • 18. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I, Beyth Y, Altaras MM, Shapira J, Tepper R, Cardoba M, Yigael D, Figer A, Fishman A, Berenhein J.
    Gynecol Oncol; 1997 Oct 21; 67(1):8-15. PubMed ID: 9345349
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
    Morelli M, Di Cello A, Venturella R, Mocciaro R, D'Alessandro P, Zullo F.
    Gynecol Endocrinol; 2013 Feb 21; 29(2):156-9. PubMed ID: 23134558
    [Abstract] [Full Text] [Related]

  • 20. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M, Piao J, Jeon MJ.
    Yonsei Med J; 2020 Apr 21; 61(4):317-322. PubMed ID: 32233174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.